Catalog No.
DHC09696
Description
Disitamab vedotin is an ADC consisting of a HER2-directed antibody and Monomethyl auristatin E (MMAE). Disitamab vedotin targets HER2 protein on tumors, recognizes and penetrates cancer cells with high precision, and releases the small molecule cytotoxic drug to kill the cancer cell. The ADC is used for the study of various cancers.
Species reactivity
Human
Clonality
Monoclonal
Target
HER2
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SEC.
Purification
Purified by Ion Exchange Chromatography.
Applications
Research Grade Biosimilar
Form
Liquid
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Alternative Names
RC48, Aidixi
Clone ID
Disitamab vedotin
For research use only. Not for human or drug use.
